血浆α-突触核蛋白可区分帕金森病与路易体痴呆
该研究利用两种选择性单克隆抗体(strain A和B)检测人脑组织、脑脊液和血浆中的α-突触核蛋白(aSyn)构象,发现帕金森病(PD)患者血浆中strain A和B aSyn水平在2个独立队列中均高于路易体痴呆(DLB)患者,且血浆strain A水平较低预测PD患者认知下降更快;这些aSyn种类在脑脊液中检测不到,脑与血浆水平不相关,但可模板化aSyn纤维化并在细胞中播种包涵体形成。
要点
- 血浆strain A和B aSyn水平在PD中高于DLB(2个独立队列)。
- 血浆strain A aSyn水平较低预测PD患者认知下降更快。
- aSyn strains在脑脊液中检测不到,脑与血浆水平不相关。
核心结论
- 循环血浆aSyn strains可能影响路易体疾病临床表现,尤其是认知。
- 这些aSyn种类在血浆而非脑脊液中富集,提示可能来源于脑外。
研究设计与样本
- 使用针对两种体外aSyn种类(strain A和B)的单克隆抗体,通过ELISA、Western blot和免疫组化表征神经正常个体和LBD患者的人体标本。
- 用种子扩增试验(SAA)和细胞模型表征从脑裂解液或血浆中免疫沉淀的aSyn种类。
主要发现
- 在2个独立队列中,PD患者血浆strain A和B aSyn水平高于DLB患者。
- 血浆strain A aSyn水平较低预测PD患者认知下降更快。
- strain A和B aSyn在脑脊液中检测不到,脑与血浆水平不相关。
- 血浆aSyn种类可模板化aSyn纤维化,并可在细胞中播种aSyn包涵体形成。
临床怎么用
- 血浆aSyn strains或可作为区分PD与DLB的候选生物标志物。
- 血浆strain A aSyn水平或有助于预测PD患者认知下降速度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aggregation of misfolded α-synuclein (aSyn) within the brain is the pathologic hallmark of Lewy body diseases (LBDs), including Parkinson's disease (PD), and dementia with Lewy bodies (DLB) disease. Although evidence exists for aSyn "strains," conformations with distinct biological properties, biomarkers for PD versus DLB are lacking. Here, we used monoclonal antibodies selective for two different in vitro aSyn species - termed strain A and B - to evaluate human brain tissue, cerebrospinal fluid (CSF), and plasma. METHODS: Using these antibodies, we characterized specific aSyn species in human specimens from neurologically normal individuals and individuals with LBD using enzyme-linked immunosorbent assay (ELISA), Western blot, and immunohistochemistry. We also characterized aSyn species immunoprecipitated from brain lysate or plasma with these antibodies using seed amplification assays (SAAs) and a cellular model. RESULTS: Surprisingly, levels of strain A and B aSyn species were higher in plasma from individuals with PD compared to DLB in 2 independent cohorts. Lower levels of plasma aSyn strain A species predicted a faster rate of cognitive decline in individuals with PD. Furthermore, strain A and strain B aSyn species were undetectable in CSF, and their levels in brain versus plasma did not correlate. Moreover, plasma aSyn species isolated by aSyn strain antibodies could template aSyn fibrillization, and they could seed formation of aSyn inclusions in cells. INTERPRETATION: Our findings suggest that circulating plasma aSyn strains may impact LBD clinical presentation, particularly cognition. The enrichment of these aSyn species in plasma but not CSF also suggests a potential source outside the brain. ANN NEUROL 2025;98:682-698.
引用
- Kannarkat GT, Zack R, Skrinak RT, et al. Blood α-Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies. Ann Neurol. 2025. PMID: 40521808. doi:10.1002/ana.27288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。